Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 2Sarcoma 1NET 1Head & Neck 1Endocrine 1

Conditions

Sarcoma 4Osteosarcoma 3Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Colorectal Neoplasms 1Carcinoid Tumor 1

Interventions

Cisplatin 5Carboplatin 5pembrolizumab 4Cyclophosphamide 4Bevacizumab 4130-nm albumin-bound paclitaxel 4Oxaliplatin 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Gemcitabine 3Fluorouracil 3Docetaxel 3Capecitabine 3tislelizumab 2fludarabine 2Specimen Handling 2Riluzole 2Quality of Life 2Psychiatric Rehabilitation 2Oncolytic Virotherapy 2Observation 2Fluorodeoxyglucose F18 2Fluorescein 2Floxuridine 2Filgrastim 2Drug Therapy 2Cetuximab 2umbralisib 1trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × surufatinib × Sarcoma × Clear all
NCT04579757 2025-05-08

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Hutchmed

Phase 1/2 Terminated
87 enrolled 29 charts
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡